No connection

Search Results

HAO vs MCHX

HAO
Haoxi Health Technology Limited
BEARISH
Price
$1.07
Market Cap
$63.6M
Sector
Communication Services
AI Confidence
75%
MCHX
Marchex, Inc.
BEARISH
Price
$1.49
Market Cap
$65.4M
Sector
Communication Services
AI Confidence
90%

Valuation

P/E Ratio
HAO
0.84
MCHX
--
Forward P/E
HAO
--
MCHX
149.0
P/B Ratio
HAO
0.18
MCHX
2.17
P/S Ratio
HAO
1.94
MCHX
1.44
EV/EBITDA
HAO
2.05
MCHX
-32.96

Profitability

Gross Margin
HAO
2.83%
MCHX
63.2%
Operating Margin
HAO
-21.16%
MCHX
-9.48%
Profit Margin
HAO
11.82%
MCHX
-11.53%
ROE
HAO
27.06%
MCHX
-16.69%
ROA
HAO
-6.74%
MCHX
-6.6%

Growth

Revenue Growth
HAO
-64.6%
MCHX
-9.0%
Earnings Growth
HAO
172.7%
MCHX
--

Financial Health

Debt/Equity
HAO
0.12
MCHX
0.02
Current Ratio
HAO
5.05
MCHX
2.36
Quick Ratio
HAO
2.4
MCHX
2.06

Dividends

Dividend Yield
HAO
--
MCHX
--
Payout Ratio
HAO
0.0%
MCHX
0.0%

AI Verdict

HAO BEARISH

HAO presents as a classic value trap, characterized by a stable Piotroski F-Score of 6/9 and a Graham Number of $13.09 that vastly exceeds the current price of $1.07. While valuation metrics like the P/E (0.84) and Price/Book (0.18) suggest extreme undervaluation, these are offset by a catastrophic YoY revenue decline of 64.60%. The disconnect between a positive net profit margin (11.82%) and a negative operating margin (-21.16%) suggests that earnings are likely driven by non-operating items rather than core business health. Combined with a 0/100 technical trend and long-term price collapse, the fundamental business decay outweighs the theoretical value.

Strengths
Extremely low P/E ratio of 0.84
Deep discount to book value (P/B 0.18)
Strong liquidity with a Current Ratio of 5.05
Risks
Severe revenue contraction (-64.60% YoY)
Negative operating margins (-21.16%) indicating core business inefficiency
Extreme bearish technical trend (0/100)
MCHX BEARISH

MCHX exhibits severe financial distress as evidenced by a Piotroski F-Score of 1/9, indicating critical weakness in operational efficiency and financial health. Despite a clean balance sheet with very low debt (D/E 0.02) and adequate liquidity, the company is struggling with negative revenue growth (-9% YoY) and consistent net losses. The forward P/E of 149.00 suggests an extremely poor earnings outlook, and the technical trend is fully bearish. While one analyst maintains a high target price of $4.00, the fundamental data does not support such a valuation.

Strengths
Very low Debt/Equity ratio (0.02)
Strong short-term liquidity (Current Ratio 2.36)
Healthy Gross Margin (63.20%)
Risks
Critical Piotroski F-Score (1/9) indicating poor financial health
Negative revenue growth both YoY and Q/Q (-9%)
Persistent unprofitability with negative ROE (-16.69%)

Compare Another Pair

HAO vs MCHX: Head-to-Head Comparison

This page compares Haoxi Health Technology Limited (HAO) and Marchex, Inc. (MCHX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile